全文获取类型
收费全文 | 788篇 |
免费 | 67篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 25篇 |
妇产科学 | 9篇 |
基础医学 | 61篇 |
口腔科学 | 11篇 |
临床医学 | 179篇 |
内科学 | 158篇 |
皮肤病学 | 17篇 |
神经病学 | 82篇 |
特种医学 | 69篇 |
外科学 | 73篇 |
综合类 | 10篇 |
一般理论 | 1篇 |
预防医学 | 59篇 |
眼科学 | 9篇 |
药学 | 53篇 |
中国医学 | 1篇 |
肿瘤学 | 30篇 |
出版年
2023年 | 19篇 |
2022年 | 4篇 |
2021年 | 18篇 |
2020年 | 13篇 |
2019年 | 10篇 |
2018年 | 18篇 |
2017年 | 17篇 |
2016年 | 18篇 |
2015年 | 19篇 |
2014年 | 24篇 |
2013年 | 47篇 |
2012年 | 42篇 |
2011年 | 34篇 |
2010年 | 30篇 |
2009年 | 34篇 |
2008年 | 36篇 |
2007年 | 33篇 |
2006年 | 27篇 |
2005年 | 28篇 |
2004年 | 29篇 |
2003年 | 29篇 |
2002年 | 38篇 |
2001年 | 44篇 |
2000年 | 21篇 |
1999年 | 21篇 |
1998年 | 17篇 |
1997年 | 16篇 |
1996年 | 16篇 |
1995年 | 5篇 |
1994年 | 14篇 |
1993年 | 9篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 9篇 |
1989年 | 16篇 |
1988年 | 11篇 |
1987年 | 3篇 |
1986年 | 15篇 |
1985年 | 11篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1976年 | 6篇 |
1975年 | 3篇 |
1973年 | 2篇 |
1968年 | 3篇 |
排序方式: 共有857条查询结果,搜索用时 15 毫秒
81.
BE Elewski Z Draelos B Dréno T Jansen A Layton M Picardo 《Journal of the European Academy of Dermatology and Venereology》2011,25(2):188-200
Background The absence of specific histological or serological markers, the gaps in understanding the aetiology and pathophysiology of rosacea, and the broad diversity in its clinical manifestations has made it difficult to reach international consensus on therapy guidelines. Objectives The main objective was to highlight the global diversity in current thinking about rosacea pathophysiology, classification and medical features, under particular consideration of the relevance of the findings to optimization of therapy. Methods The article presents findings, proposals and conclusions reached by the ROSacea International Expert group (ROSIE), comprising European and US rosacea experts. Results New findings on pathogenesis provide a rationale for the development of novel therapies. Thus, recent findings suggest a central role of the antimicrobial peptide cathelicidin and its activator kallikrein‐5 by eliciting an exacerbated response of the innate immune system. Cathelicidin/kallikrein‐5 also provide a rationale for the effect of tetracyclines and azelaic acid against rosacea. Clinically, the ROSIE group emphasized the need for a comprehensive therapy strategy – the triad of rosacea care – that integrates patient education including psychological and social aspects, skin care with dermo‐cosmetics as well as drug‐ and physical therapies. Classification of rosacea into stages or subgroups, with or without progression, remained controversial. However, the ROSIE group proposed that therapy decision making should be in accordance with a treatment algorithm based on the signs and symptoms of rosacea rather than on a prior classification. Conclusion The ROSIE group reviewed rosacea pathophysiology and medical features and the impact on patients and treatment options. The group suggested a rational, evidence‐based approach to treatment for the various symptoms of the condition. In daily practice this approach might be more easily handled than prior subtype classification, in particular since patients often may show clinical features of more than one subtype at the same time. 相似文献
82.
Jessica Dillard-Wright PhD MA RN CNM Claire Valderama-Wallace PhD MPH RN Lucinda Canty PhD CNM RN FACNM Amélie Perron RN PhD Ismalia De Sousa RN MSc Janice Gullick RN MFA PhD 《Nursing philosophy》2023,24(3):e12443
Drawing from a keynote panel held at the hybrid 25th International Philosophy of Nursing Conference, this discussion paper examines the question of epistemic silence in nursing from five different perspectives. Contributors include US-based scholar Claire Valderama-Wallace, who meditated on ecosystems of settler colonial logics of nursing; American scholar Lucinda Canty discussed the epistemic silencing of nurses of colour; Canadian scholar Amelie Perron interrogated the use of disobedience and parrhesia in and for nursing; Canada-based scholar Ismalia De Sousa considered what nursing protects in its silences; and Australian scholar Janice Gullick spoke to trans invisibility in nursing. 相似文献
83.
84.
Gerbaud E Harcaut E Coste P Erickson M Lederlin M Labèque JN Perron JM Cochet H Dos Santos P Durrieu-Jaïs C Laurent F Montaudon M 《The international journal of cardiovascular imaging》2012,28(4):783-794
To evaluate the incremental diagnostic and prognostic value of cardiac magnetic resonance (CMR) in patients with chest pain, raised troponin and unobstructed coronary arteries, and to compare subsequent event rates between diagnostic groups. 130 patients (mean age: 54?±?17) presenting with troponin-positive acute chest pain and unobstructed coronary arteries were included. All patients were managed according to European Society of Cardiology guidelines, including echocardiography, and had CMR within 6.2?±?5.3?days of presentation. During follow-up, major adverse cardiovascular events (MACE) were recorded. CMR provided a diagnosis in 100 of 130 patients (76.9%), with the remaining 30 (23.1%) having a normal examination. CMR diagnosed 37 (28.5%) acute myocardial infarctions, 34 (26.1%) myocarditis, 28 (21.5%) apical ballooning syndromes and 1 (0.8%) hypertrophic cardiomyopathy. When a single diagnosis was suspected by the referring physician, CMR validated this diagnosis in 32 patients (76.2%). CMR provided a formal diagnosis in 61 patients (69.3%) in which the clinical diagnosis was uncertain between at least two possibilities. CMR corrected a wrong diagnosis in 10 patients (7.7%). CMR-suggested diagnosis led to a modification of therapy in 42 patients (32.3%). Median follow-up was 34?months (interquartile range 24–49) in 124 patients. Sixteen patients (12.9%) experienced MACE. MACE rate was not different between patients with a conclusive CMR and normal CMR. In patients with acute troponin-positive chest pain and unobstructed coronary arteries, early CMR has important diagnostic and therapeutic implications. However its association with occurrence of MACE during mid term follow-up was not obvious. 相似文献
85.
Perron BE Glass JE Ahmedani BK Vaughn MG Roberts DE Wu LT 《Substance abuse and rehabilitation》2011,2011(2):69-76
BACKGROUND: Inhalants are among the most common and dangerous forms of substance use, but very little research on inhalant use disorders exist. Unlike other substances, the Diagnostic and Statistical Manual, 4th edition (DSM-IV) indicates that inhalants do not have an associated withdrawal syndrome among persons who meet criteria for inhalant dependence. METHODS: Using data from the National Epidemiologic Survey on Alcohol and Related Conditions, this study examines the prevalence of withdrawal symptoms among inhalant users. Prevalence of inhalant withdrawal symptoms for inhalants was also compared with the prevalence of cocaine withdrawal symptoms to help determine the presence of an inhalant withdrawal syndrome. RESULTS: Approximately 47.8% of persons who met criteria for inhalant dependence reported experiencing three or more inhalant-related withdrawal symptoms that were clinically significant. Among those with inhalant dependence, almost half of the withdrawal symptoms were as common as the corresponding withdrawal symptoms experienced by persons with cocaine dependence. Furthermore, the percentage of persons with inhalant dependence reporting clinically significant inhalant withdrawal symptoms was almost equal to the percentage of persons with cocaine dependence reporting clinically significant cocaine withdrawal symptoms. CONCLUSIONS: These data provide evidence for an inhalant-related withdrawal syndrome among persons with inhalant dependence. Revisions to DSM-IV should consider including inhalant withdrawal as a diagnostic criterion for this disorder. 相似文献
86.
87.
88.
C Malcus-Vocanson P Giraud F Micoud V Janin M H Charles E Broussolle G Chazot B Mandrand H Perron 《Multiple sclerosis (Houndmills, Basingstoke, England)》2001,7(6):383-388
The biochemical and biological characterization of a cytotoxic activity targeting macroglial cells (oligodendrocytes and astrocytes), in moncyte cultures and in CSF of a patient with multiple sclerosis, has previously been described. In further studies, cell-based tests have shown a good correlation between this glial cytotoxic (gliotoxic) activity, in CSF or in urine, and MS. We now present results obtained with urine samples from 102 MS patients, 51 patients with other neurological disease and 35 healthy subjects using a bioassay set up for the detection of an apoptosis-like effect induced in a glial cell-line. Significant gliotoxicity was detected in urine from 74/102 MS patients while only 4/51 neurological controls (P>0.001) and never in healthy subjects (P>0.001). Given the statistical tendency provided by this bioassay and its technical limitations for routine testing, it is now used for monitoring the molecular characterization of this 'gliotoxic factor'. Its replacement by a specific immunoassay could provide more accurate routine techniques for the detection of this biological marker in MS. 相似文献
89.
90.
Influence of time elapsed between myocardial infarction and coronary artery bypass grafting surgery on operative mortality. 总被引:1,自引:0,他引:1
Pierre Voisine Patrick Mathieu Daniel Doyle Jean Perron Richard Baillot Gilles Raymond Jacques Métras Fran?ois Dagenais 《European journal of cardio-thoracic surgery》2006,29(3):319-323
OBJECTIVE: Optimal timing for CABG surgery after myocardial infarction (MI) remains controversial. We examined the influence of patient age and time elapsed between MI and isolated CABG surgery on operative mortality. METHODS: Perioperative data of 13,545 patients who underwent isolated CABG surgery from 1991 to 2005 were reviewed. A previous MI was found in 7219 patients, classified among groups A-E whether they underwent surgery less than 6h (A, n=26), between 6 and 24h (B, n=51), between 1 and 7 days (C, n=313), between 8 and 30 days (D, n=917), or more than 30 days (E, n=5912) after the event. Crude percentages and odds ratio estimates of operative mortality were calculated. RESULTS: In patients who had no history of MI, the mortality rate was 1.7%, while it was, respectively, 19.2, 9.8, 8.6, 3.2, and 2.4% in patients from groups A to E. Among 6589 patients over 65 years of age, 3027 had no history of MI. Their mortality was 2.4%, compared to, respectively, 35.7, 13.8, 11.3, 5.1, and 3.9% for those belonging to groups A-E. Overall odds ratio estimates of operative mortality were 3.92 (p=0.19), 5.08 (p=0.002), 4.33 (p=0.0001), 1.50 (p=0.08), and 1.18 (p=0.24) for groups A-E, respectively. CONCLUSIONS: Operative mortality is not influenced by a history of MI sustained more than 30 days prior to isolated CABG surgery, but is highly and most significantly increased between 6h and 1 week after MI, especially in older patients. That critical period should be avoided whenever possible. 相似文献